Guardant Health, Inc. (GH): Price and Financial Metrics
Guardant Health, Inc. (GH)
Today's Latest Price: $75.90 USD
3.37 (4.65%)
Updated Dec 13 12:00am
Add GH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 131 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
GH Daily Price Range
GH 52-Week Price Range
GH Stock Price Chart More Charts
GH Price/Volume Stats
| Current price | $75.90 | 52-week high | $112.21 |
| Prev. close | $72.53 | 52-week low | $32.33 |
| Day low | $73.01 | Volume | 668,400 |
| Day high | $76.03 | Avg. volume | 1,066,362 |
| 50-day MA | $70.96 | Dividend yield | N/A |
| 200-day MA | $78.74 | Market Cap | 7.13B |
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...